XPO1 inhibitors represent a novel therapeutic option in Adult T-cell Leukemia, triggering p53-mediated caspase-dependent apoptosis

Eline Boons, Tatiane C. Nogueira, Tim Dierckx, Soraya Maria Menezes, Maarten Jacquemyn, Sharon Tamir, Yosef Landesman, Lourdes Farré, Achiléa Bittencourt, Keisuke Kataoka, Seishi Ogawa, Robert Snoeck, Graciela Andrei, Johan Van Weyenbergh, Dirk Daelemans

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Article number27
JournalBlood cancer journal
Volume11
Issue number2
DOIs
Publication statusPublished - 2021 Feb
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this